PerkinElmer Labs, Inc.

What PerkinElmer Labs, Inc. does

PerkinElmer Labs, Inc. is a private, for-profit company headquartered in Melville, United States, that provides research and development services for prenatal screening protocols. Founded in 1983 and operating under the web domain ntdlabs.com, the company serves the antenatal screening market, where it is identified as one of the key players alongside larger diagnostics incumbents such as Siemens Healthineers and Thermo Fisher Scientific. Its 40-plus-year operating history suggests an established niche rather than an early-stage entrant.

The company's offering is narrowly focused on R&D services supporting prenatal screening protocols rather than broad commercial diagnostic products or platforms. As a niche services provider in a specialized clinical vertical, PerkinElmer Labs occupies a position that requires domain expertise in prenatal screening science and likely clinical laboratory regulatory compliance. The broader prenatal testing market in which it operates is projected to grow substantially through 2033, providing a demand-side tailwind for the company's underlying serviceable market.

The company's business model and revenue mechanics are not publicly disclosed in the available source material. No headcount, customer roster, pricing model, funding rounds, or financial figures are present in the data, which limits visibility into commercial scale, segment mix, and operating economics. Its private status, absence of disclosed funding activity, and lack of a confirmed parent-company relationship in the data leave ownership structure and capital posture ambiguous; it could be a self-sustaining profitable niche operator, a captive R&D arm of a larger corporate parent, or a dormant legacy entity with limited current activity.

Name

PerkinElmer Labs, Inc.

Website

https://ntdlabs.com

Company type

Private

Founded year

1983

Short description

PerkinElmer Labs, Inc. is a private, U.S.-based research and development services company founded in 1983 that supports prenatal screening protocols. It operates as a niche player in the antenatal screening market alongside larger diagnostics firms.

Ownership category

akta.pro rank

Product category

Prenatal Screening Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Genetic & Prenatal Testing Laboratories (HLAFAMAH)

akta.pro secondary industries

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

Keywords

• Prenatal screening services
• Research and development
• Clinical diagnostics
• Antenatal testing
• Medical laboratory services

Headquarters

HQ city

Melville

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Core offering

PerkinElmer Labs, Inc. provides research and development services for prenatal screening protocols. The company operates as a for-profit laboratory service provider based in Melville, United States, founded in 1983, operating under the web domain ntdlabs.com. Its activities center on advancing and validating diagnostic approaches for the antenatal screening market.

Differentiator

Problem solved

Functional benefit

Products and services

• Prenatal Screening Protocol R&D Services Research and development services focused on advancing prenatal screening protocols for the antenatal diagnostic market. The offering targets healthcare and clinical laboratory customers requiring validated screening methodologies.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Expansion highlights1 record

Broad incumbents

• Quest Diagnostics: Quest Diagnostics operates one of the largest U.S. clinical lab networks and provides prenatal screening and carrier screening services through its QNatal and other offerings — directly overlapping in test menu and provider customers, embedded within a much wider lab portfolio.
• Hologic: Hologic's Diagnostics division offers molecular and cytology products used in prenatal and women's health screening (e.g., HPV, cytogenetics), serving the same OB/GYN and women's health provider channel though across a broader diagnostics menu.
• Thermo Fisher Scientific: Thermo Fisher Scientific is explicitly named as a key player in the antenatal screening market and supplies a broad prenatal screening product portfolio (reagents, instruments, software) that competes with lab-developed testing protocols, though within a vastly larger life sciences catalog.
• Siemens Healthineers: Siemens Healthineers is explicitly named as a key player in the antenatal screening market, offering laboratory diagnostic solutions (including prenatal screening assays) that compete for the same hospital and reference lab customers, embedded within a global diagnostics and imaging portfolio.
• LabCorp: LabCorp is one of the largest U.S. clinical laboratory networks and offers prenatal screening (including its integrated Invitae reproductive health genetic testing) — directly overlapping in service menu and customer base, but as part of a very broad diagnostic portfolio.

Direct peers

• Natera: Natera is a leading molecular diagnostics company focused on reproductive health, with cell-free DNA-based NIPT offerings (e.g., Panorama) that directly compete with traditional prenatal screening labs in the same customer segment (OB/GYNs, MFM specialists) and on overlapping indications (aneuploidy screening).
• Myriad Genetics: Myriad Genetics operates a women's health molecular diagnostics franchise (including the Foresight carrier screen and AMPLIFY NIPT platform) that overlaps directly with prenatal aneuploidy and carrier screening services offered by perinatal clinical labs.
• Invitae: Invitae (now operating within LabCorp) specializes in reproductive health genetic testing including PGT, NIPT, and carrier screening — directly mirroring the prenatal screening use case and OB/GYN customer base of a focused prenatal lab.
• Fulgent Genetics: Fulgent Genetics offers reproductive health and NIPT services through its Fulgent Genetics and Inform Diagnostics brands, directly competing for prenatal screening volume from OB/GYNs and maternal-fetal medicine practices.

Others

• Eurofins: Eurofins operates a global Clinical Diagnostics service line that includes prenatal and reproductive health testing across multiple geographies — adjacent to the perinatal lab offering but as part of a much broader life sciences testing portfolio.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks2 records

Key highlights3 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PerkinElmer Labs, Inc.